Aimmune Therapeutics, Inc.

Historical 13F Holders

Symbol
AIMT
CUSIP
00900T107
All holders as of
Q3 2021
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2021 Q3 1 1.00 $0
2021 Q2 1 0 $0
2021 Q1 1 0 $0
2020 Q4 1 0 $0
2020 Q3 211 43.7 M $1.50 B
2020 Q2 180 49.3 M $824 M
2020 Q1 176 49.7 M $711 M
2019 Q4 173 47.5 M $1.59 B
2019 Q3 171 52.2 M $1.09 B
2019 Q2 144 49.4 M $1.03 B
2019 Q1 139 47.9 M $1.07 B
2018 Q4 139 46.4 M $1.11 B
2018 Q3 164 45.1 M $1.23 B
2018 Q2 165 46.7 M $1.25 B
2018 Q1 167 46.8 M $1.49 B
2017 Q4 135 37.3 M $1.41 B
2017 Q3 112 37.3 M $925 M
2017 Q2 98 36.8 M $757 M
2017 Q1 92 35.5 M $772 M
2016 Q4 96 33.4 M $683 M
2016 Q3 76 30.3 M $454 M
2016 Q2 75 29.1 M $319 M
2016 Q1 71 27.5 M $374 M
2015 Q4 60 25.8 M $476 M
2015 Q3 58 21.8 M $551 M